Correlation Between Beyond Air and Context Therapeutics
Can any of the company-specific risk be diversified away by investing in both Beyond Air and Context Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beyond Air and Context Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beyond Air and Context Therapeutics, you can compare the effects of market volatilities on Beyond Air and Context Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beyond Air with a short position of Context Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beyond Air and Context Therapeutics.
Diversification Opportunities for Beyond Air and Context Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Beyond and Context is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Beyond Air and Context Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Context Therapeutics and Beyond Air is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beyond Air are associated (or correlated) with Context Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Context Therapeutics has no effect on the direction of Beyond Air i.e., Beyond Air and Context Therapeutics go up and down completely randomly.
Pair Corralation between Beyond Air and Context Therapeutics
Given the investment horizon of 90 days Beyond Air is expected to under-perform the Context Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Beyond Air is 1.1 times less risky than Context Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Context Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 110.00 in Context Therapeutics on December 27, 2024 and sell it today you would lose (36.35) from holding Context Therapeutics or give up 33.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Beyond Air vs. Context Therapeutics
Performance |
Timeline |
Beyond Air |
Context Therapeutics |
Beyond Air and Context Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Beyond Air and Context Therapeutics
The main advantage of trading using opposite Beyond Air and Context Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beyond Air position performs unexpectedly, Context Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Context Therapeutics will offset losses from the drop in Context Therapeutics' long position.Beyond Air vs. Lucid Diagnostics | Beyond Air vs. PAVmed Series Z | Beyond Air vs. Clearpoint Neuro | Beyond Air vs. Avita Medical |
Context Therapeutics vs. Terns Pharmaceuticals | Context Therapeutics vs. Amylyx Pharmaceuticals | Context Therapeutics vs. Acumen Pharmaceuticals | Context Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |